In agreement, blocking the HER3 ligand (Supplementary Fig. S19) significantly reduced binding to both human (Hu) and mouse (Mu) HER3+ tumour cell lines and highlights the species cross-reactivity of HPK which is supported by the high amino acid sequence identity between human and mouse HER3 (Fig. 2b)35. Here, ERBB3 is linked to neoplasm.